The pharmaceutical industry is undergoing a paradigm shift, leveraging cutting-edge technologies to expedite the drug discovery and development process. This transformation has opened up new opportunities to improve healthcare outcomes,

Human-induced pluripotent stem cell (iPSC) technology has revolutionized the field of drug discovery and toxicity testing. iPSCs are generated from adult somatic cells, such as skin or blood cells, by

Testing the biological activity of pharmaceutical drugs, agro-chemicals and other xenobiotics on human relevant systems has increasingly become an important regulatory requirement to make a go or no-go decision (drug